Pmv Pharmaceuticals Inc (PMVP NASDAQ) stock market data APIs
$1.237
0.01(0.8%)
as of September 18, 2025
Try our APIs with
free plan!
Pmv Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Prev. Close
1.237
Open
1.2516
High
1.3147
Low
1.1839
52 wk Range
0.81-1.84
Market Cap
65 179 K
Shares Outstanding
52 991 K
EPS
-0.41
Beta
1.515
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pmv Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pmv Pharmaceuticals Inc data using free add-ons & libraries
Get Pmv Pharmaceuticals Inc Fundamental Data
Pmv Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -90 422 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pmv Pharmaceuticals Inc News
New
Get insights into the top gainers and losers of Wednesday's pre-market session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] PRE-MARKET GAINERS TICKER CHANGE ...
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
PYNNACLE Phase 2 pivotal clinical trial interim data include confirmed responses observed in eight tumor types spanning ovarian, lung, breast, endometrial, head and neck,colorectal, gallbladder, and a...
PMV Pharmaceuticals GAAP EPS of -$0.41 misses by $0.02
* PMV Pharmaceuticals press release [https://seekingalpha.com/pr/20193264-pmv-pharmaceuticals-reports-second-quarter-2025-financial-results-and-corporate-highlights] (NASDAQ:PMVP [https://seekingalp...
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
PMV will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review Phase 2 PYNNACLE clinical trial interim analysis Interim analysis will include data for approximately 65 pati...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
